Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections막 보조인자 단백질(MCP; CD46): 결핍 상태 및 병원체 연결Review Published on 2021-10-012022-09-11 Journal: Current opinion in immunology [Category] SARS, 변종, [키워드] 2019 autophagy C3b Cancer cancers CD46 cleave cofactor complement complement system connection contribute coronavirus disease COVID-19 deficiency disease-causing expressed function host cells inflammatory disorders member modulating overexpression pathogen Pathogens Protein receptor Regulatory Serine serine protease T cell T cell activation therapeutic Vaccines variant vectors while [DOI] 10.1016/j.coi.2021.04.005 PMC 바로가기 [Article Type] Review
The Rise of Vectored Vaccines: A Legacy of the COVID-19 Global CrisisReview Published on 2021-09-292022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] addition amplitude approved China clinical trials COVID-19 COVID-19 pandemic crisis Effectiveness effort EUA favor highlight immune responses immunization immunogen Influenza virus involved janssen Johnson & Johnson legacy New New coronavirus platform recombinant viral vectors Research SARS-CoV-2 the vaccine Tianjin triggered Vaccine vaccinia vectors Viral vector virus [DOI] 10.3390/vaccines9101101 PMC 바로가기 [Article Type] Review
Application of Nanomaterials as an Advanced Strategy for the Diagnosis, Prevention, and Treatment of Viral DiseasesReview Published on 2021-09-272022-10-28 Journal: Pharmaceutics [Category] COVID-19, [키워드] application applied approach Clinical use contribute coronavirus disease COVID-19 develop Diagnosis diagnostic systems Diseases elevated Health increasingly infection control Infectious disease inhibitors intrinsic limit limitation Nanomaterial nanomaterials outbreak pandemic pathogen physicochemical property physiological platform prevention Prophylactic Safety Strategy Therapeutics Treatment Vaccines variants vectors Viral diseases [DOI] 10.3390/pharmaceutics13101570 PMC 바로가기 [Article Type] Review
Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2쥐에 적응한 SARS-CoV-2에 대한 붉은 털모자 아데노바이러스 COVID-19 백신의 보호 효능Vaccines and Antiviral Agents Published on 2021-09-152022-09-12 Journal: Journal of Virology [Category] MERS, SARS, 진단, [키워드] Adenovirus adenoviruses animal model animal models Antibody Response binding candidate clinical disease correlated COVID-19 COVID-19 disease COVID-19 pandemic driving Efficacy elicit elicited evaluate evaluated Human immune correlate immune correlates infect Laboratory live vector vaccines Lungs mechanism mice model systems mouse-adapted SARS-CoV-2 Neutralizing antibody titer neutralizing antibody titers probe PROTECT Protective reported respiratory symptoms respiratory tract tissue respiratory tract tissues rhesus robust SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines SARS-CoV-2 virus serotype Support These data to define Vaccine vaccine candidate vaccine candidates Vaccine development vector vectors viral replication virus virus strain wild-type [DOI] 10.1128/JVI.00974-21 PMC 바로가기 [Article Type] Vaccines and Antiviral Agents
Could live attenuated vaccines better control COVID-19?약독화 생백신이 COVID-19를 더 잘 통제할 수 있습니까?Review Published on 2021-09-152022-09-11 Journal: Vaccine [Category] SARS, 변종, 유전자 메커니즘, [키워드] Adenovirus adenovirus vectored vaccine adverse effects anti-SARS-CoV-2 vaccine anti-SARS-CoV-2 vaccines antibody approved arising attenuated vaccine can be used Characteristics country COVID-19 COVID-19 pandemic COVID-19 vaccines develop Disadvantages effective Efficacy effort Fever hindrance Humoral immunity IMPROVE Inactivated vaccine Inactivated Vaccines inactivated viruses induce Live attenuated vaccine Live attenuated vaccines live-attenuated vaccines mRNA vaccine mRNA vaccines mRNAs natural infection pandemic patients phenotype pre-existing immunity repertoire replicate SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines seeds serum strain the disease thrombosis unique Usage vaccination Vaccinations Vaccine variants variants of SARS-CoV-2 vectors [DOI] 10.1016/j.vaccine.2021.08.018 PMC 바로가기 [Article Type] Review
Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formationSARS-CoV-2 Spike의 세포질 꼬리에 있는 서열은 세포 표면에서의 발현 및 합포체 형성을 촉진합니다Article Published on 2021-09-092022-09-10 Journal: Nature Communications [Category] SARS, 변종, 유전자 메커니즘, [키워드] accumulate ACE2 Actin Adenovirus autophagy bind binding C-terminal Cell cell surface cellular COPI COPII cytoplasmic tail direct fusion domain Endoplasmic reticulum exit expressing expression facilitate Factor full-length S fusion Golgi histidine host cells induce Interaction lifecycle mass spectrometry motif mRNA promote Protein proteomic residue RNA vaccines SARS-CoV-2 SARS-COV-2 infection sequence sequences spike Spike protein Syncytia syncytia formation tail the cell the SARS-CoV-2 transmembrane domain understanding Vaccine vectors Vesicle Viral Virus-host interactions [DOI] 10.1038/s41467-021-25589-1 PMC 바로가기 [Article Type] Article
New Distribution Records of Anopheles darlingi in Quintana Roo, Southeastern MexicoArticle Published on 2021-09-012024-08-28 Journal: J Am Mosq Control Assoc [Category] 말라리아, [키워드] Anophelinae malaria vectors
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge인간 세포 기반 SARS-CoV-2 백신은 강력한 중화 항체 반응을 유도하고 SARS-CoV-2 공격으로부터 마우스를 보호합니다Research Article Published on 2021-08-122022-09-10 Journal: Emerging Microbes & Infections [Category] SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration ameliorated Antibody titer approach caused Cell cell-based vaccines cellular convalescent serum coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 demonstrated develop effective Efficacy elicit exposure to external gene external genes formalin generate greater hACE2 human cell immunization in viral inactivated Inactivated vaccine induce K562-S Log reduction lung Lung pathology membrane MERS-CoV mice mouse model NAb neutralizing antibody Neutralizing antibody response Neutralizing antibody titer non-human primate non-human primate model non-human primates pandemic platform promise PROTECT protection Protective Protein regimen respiratory response S-protein Safe SARS-CoV SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 mutants SARS-CoV-2 vaccine severe acute respiratory syndrome Coronavirus spike Support turn vaccination Vaccine vaccine candidate vectors viability Viral X-ray [DOI] 10.1080/22221751.2021.1957400 PMC 바로가기 [Article Type] Research Article
Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19중증 COVID-19의 경우 신종 감염병에 대한 마우스 모델의 신속한 생성Research Article Published on 2021-08-112022-09-12 Journal: PLoS Pathogens [Category] MERS, 진단, [키워드] adeno-associated virus animal model antibody cocktail applied approach COVID-19 demonstrated disease Drug development Efficacy expressing expression hACE2 Infectious disease Infectious diseases mechanism mice mimicking mouse model multi pandemic of COVID-19 pathogen pathophysiology patients Rapid receptor receptor hACE2 Research SARS-CoV-2 SARS-COV-2 infection severe COVID-19 the disease the patient therapeutic Therapeutics utility vector vectors virus was tested wild-type [DOI] 10.1371/journal.ppat.1009758 PMC 바로가기 [Article Type] Research Article
SARS-CoV-2 and the Brain: What Do We Know about the Causality of ‘Cognitive COVID?Review Published on 2021-08-022022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] approach Brain Causality caused changes in cognitive Cognitive impairment consequence coronavirus disease correlations COVID-19 COVID-19 case Deleterious delirium Diagnosis domains encephalopathy-like symptoms event Evidence exhibiting Healthcare system hematogenous highlight identify Immune cell Infection Inflammation intubation management mechanism mechanisms memory MERS-CoV mitigate mRNA neuronal neurotropism olfactory outbreak pandemic pathway Patient Prevalence prevention pro-inflammatory state proportion psychosocial stressor Quality of life raised rehabilitation risk SARS-CoV SARS-CoV-2 SARS-COV-2 infection spike glycoprotein Spread Symptom Symptoms syndrome Transmission unique Vaccine vectors virus [DOI] 10.3390/jcm10153441 PMC 바로가기 [Article Type] Review